Press

Red Light Holland Psilocybin Microdosing Capsules Aimed To Be Distributed by Nubu Pharmaceuticals In Australia Pass 8 Weeks of Stability Testing By CCREST Laboratories

Aug 28 • 4 min read

Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) (“Red Light Holland” or the “Company”), a company engaged in the production, growth and sale of functional mushrooms and mushroom home grow kits in North America and Europe and a premium brand of psilocybin truffles to the legal, recreational market within the Netherlands, in compliance…

Cybin to Acquire Small Pharma Inc.

Aug 28 • 13 min read

–All-share transaction creates international clinical-stage leader in novel psychedelic therapeutics – – Two proprietary, advanced clinical programs in development for depression and anxiety disorders with demonstrated safety and efficacy – – Combined portfolio creates the industry’s largest, most advanced, well-protected deuterated DMT program – – Combination creates the largest intellectual property portfolio in the psychedelic…

Irwin Naturals Reports Q2 2023 Financial Results

Aug 28 • 12 min read

Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) reported its financial results for its second quarter of fiscal 2023, the period ended June 30, 2023, on www.sedar.com. Financial Highlights for Q2 2023 Financial Highlights for Year to Date June 30, 2023 Operational Highlights Irwin Naturals has continued its expansion into the high-growth cannabis and…

Canadian Survey Shows People Aren’t Talking to Doctors About Medical Use of Psychedelics

Aug 25 • 3 min read

A recent Canadian survey has revealed that an increasing number of people are taking psychedelics for therapeutic purposes but aren’t discussing their psychedelic use with their doctors. The poll discovered that Canadians are specifically using hallucinogens to address mental health challenges but aren’t informing their physicians about the psychedelic use. Published in the “Journal of…

Sunstone Therapies in Collaboration with the University of Vermont Announces Publication of Study Showing Feasibility of Direct Observation of Therapeutic Connection in Psilocybin-Assisted Therapy

Aug 25 • 3 min read

Sunstone Therapies in Collaboration with the University of Vermont Announces Publication of Study Showing Feasibility of Direct Observation of Therapeutic Connection in Psilocybin-Assisted Therapy Study demonstrates potential to operationalize observation of therapeutic connection with implications for therapist training and clinical settings Sunstone Therapies, a leader in the delivery of psychedelic-assisted therapy in the medical setting…

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435